Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VTGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

VistaGen Therapeutics Inc stock price down 1.86% on Wednesday
(Updated on May 01, 2024)

Buy candidate since Apr 30, 2024 Loss -1.86% PDF

The VistaGen Therapeutics Inc stock price fell by -1.86% on the last day (Wednesday, 1st May 2024) from $4.83 to $4.74. During the last trading day the stock fluctuated 4.24% from a day low at $4.72 to a day high of $4.92. The price has risen in 7 of the last 10 days and is up by 1.5% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -342 thousand shares and in total, 132 thousand shares were bought and sold for approximately $625.59 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect VistaGen Therapeutics Inc stock with a 90% probability to be traded between $3.85 and $5.32 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VTGN Signals & Forecast

The VistaGen Therapeutics Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.76. On a fall, the stock will find some support from the long-term average at approximately $4.73. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 1.94%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.49 and $4.24. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, VistaGen Therapeutics Inc finds support just below today's level at $4.49. If this is broken, then the next support from accumulated volume will be at $4.24 and $4.17.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.200 between high and low, or 4.24%. For the last week the stock has had daily average volatility of 4.96%.

Our recommended stop-loss: $4.45 (-6.13%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (VTGN) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect VistaGen Therapeutics Inc to open at $4.79, and during the day (based on 14 day Average True Range), to move between $4.47 and $5.01, which gives a possible trading interval of +/-$0.270 (+/-5.70%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 11.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.49 (5.27%) than the resistance at $5.28 (11.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is VistaGen Therapeutics Inc stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for VistaGen Therapeutics Inc stock to perform well in the short-term period.

Current score: 1.319 Buy Candidate Unchanged

Predicted Opening Price for VistaGen Therapeutics Inc of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$4.79 ( 1.13%) $4.74

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VTGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.99 5.34 %
R2 4.92 3.73 %
R1 4.87 2.74 %
Current price: 4.74
Support S1 4.72 -0.487 %
S2 4.67 -1.48 %
S3 4.59 -3.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.40 13.92 %
R2 5.29 11.60 %
R1 5.28 11.39 %
Current price 4.74
Support S1 4.49 -5.27%
S2 4.24 -10.65%
S3 4.17 -12.03%

FAQ

What is the symbol for VistaGen Therapeutics Inc Stock and on which exchange is it traded?
The symbol for VistaGen Therapeutics Inc is VTGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell VistaGen Therapeutics Inc Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for VistaGen Therapeutics Inc stock to perform well in the short-term period.

How to buy VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.

What's the current price of VistaGen Therapeutics Inc Stock?
As of the end of day on the May 01, 2024, the price of an VistaGen Therapeutics Inc (VTGN) share was $4.74.

What is the 52-week high and low for VistaGen Therapeutics Inc Stock?
The 52-week high for VistaGen Therapeutics Inc Stock is $24.71 and the 52-week low is $1.62.

What is the market capitalization of VistaGen Therapeutics Inc Stock?
As of the May 01, 2024, the market capitalization of VistaGen Therapeutics Inc is 128.099M.

When is the next earnings date for VistaGen Therapeutics Inc?
The upcoming earnings date for VistaGen Therapeutics Inc is May 29, 2024.
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT